Morgan Stanley downgrades $AGN

Citigroup reiterates buy on Allergan PLC. (AGN) with target of $280, while Morgan Stanley downgrades AGN from overweight to equal weight, revising target from $284 to $228. Could impact the share price.

Check out more ratings on our SeekingAlpha Marketplace Daily Pharma Scoop.